Loading organizations...

§ Private Profile · Mountain View, CA, USA
Syllable is a technology company.
Syllable has raised $72.0M across 3 funding rounds.
Key people at Syllable.
Syllable has raised $72.0M in total across 3 funding rounds.
Syllable provides an Agentic Platform for enterprises to build, deploy, and optimize AI agents across voice, SMS, and chat. The platform features prompt editing, multilingual support, and real-time monitoring, designed for scalable operations and continuous improvement. It upholds enterprise-grade security and regulatory compliance, with SOC 2 and HIPAA certifications, ensuring data protection and adherence to industry standards.
Co-founded by Kobus Jooste, Andrew Rogers, and Gui Bastos, Syllable leverages CEO Jooste's prior experience as a Google engineering director. The founders identified a need to apply advanced artificial intelligence to modernize patient engagement and customer service within healthcare, leading to their specialized communication platform.
Syllable primarily serves healthcare systems, streamlining patient interactions and reducing administrative burdens. The platform integrates empathy, transparency, and intelligence into patient touchpoints. The company's vision is to reshape how healthcare providers build and sustain patient relationships, utilizing AI for more efficient and personalized experiences.
Key people at Syllable.
Syllable is a healthcare-focused AI company that builds voice, SMS and web AI agents to automate patient-facing communications and call-center workflows for health systems and enterprises. Syllable’s platform emphasizes HIPAA-compliant conversational automation, analytics, and deployment tools for voice and chat channels to reduce call volumes and speed patient access to care[1][3].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick takeaway: Syllable positions itself at the intersection of conversational AI and regulated healthcare workflows—offering a compliant, production-ready agent platform that targets urgent operational pain points in hospitals and health systems and appears to be scaling through enterprise customers and strategic acquisitions[1][3][2].
Notes and sources: Company profile and product details from Syllable’s website (product, compliance, features)[3]; industry reporting and company profile summaries (CB Insights) including founding year, customer mentions, and acquisition activity[1]; business profiles and funding/employee summaries (ZoomInfo, Great Place to Work)[2][4].
Syllable has raised $72.0M in total across 3 funding rounds.
Syllable's investors include Matt Brennan, Oak HC/FT, Section 32, Verily, BlueCross BlueShield Venture Partners, CVS Health, Sandbox Industries, Boldstart Ventures, Danmar Capital, Matchstick Ventures, Jim Young.
Syllable has raised $72.0M across 3 funding rounds. Most recently, it raised $40.0M Series C in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 25, 2022 | $40M Series C | Matt Brennan | OAK HC/FT, Section 32, Verily | Announced |
| Jun 1, 2021 | $28M Series B | OAK HC/FT | Bluecross Blueshield Venture Partners, CVS Health, Sandbox Industries, Section 32 | Announced |
| Mar 1, 2017 | $4M Seed | — | Boldstart Ventures, Danmar Capital, Matchstick Ventures, JIM Young | Announced |